openPR Logo
Press release

Cushing's Syndrome Market is expected to reach US$ 291.1 million by 2031 growing with a CAGR of 8.96% | LGM Pharma, Sigma Aldrich, Tocris Bioscience.

04-14-2025 11:27 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Cushing's Syndrome Market

Cushing's Syndrome Market

The latest report published by DataM Intelligence highlights the growth prospects of Cushings Syndrome market. The industry expansion is majorly driven by developments in technology across the globe.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cushings-syndrome-market?rk

Global Cushing's Syndrome market reached US$ 146.5 million in 2023 and is expected to reach US$ 291.1 million by 2031 growing with a CAGR of 8.96% during the forecast period 2024-2031.

The Cushing's Syndrome market addresses treatment solutions for hormonal disorders caused by prolonged cortisol exposure. The condition can result from tumors or long-term corticosteroid use. Treatment options include surgery, radiation, and drug therapies targeting cortisol production. Market growth is driven by increasing awareness, improved diagnostic tools, and orphan drug designations. Research into novel therapies and early detection is expanding the market landscape.

Competitive Evaluation:

Companies covered in this report are Corcept Therapeutics, Piramal Pharma Solutions, LGM Pharma, Sigma Aldrich, Tocris Bioscience, Tecoland Corporation, Sparrow Pharmaceuticals, Novartis AG, Xeris Biopharma, and Zhejiang Supor Pharmaceuticals Co. Ltd.

The Cushings Syndrome Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.

Key Development

In February 2023, Bristol Practice introduced an innovative 3D printing guide designed to assist in Cushing's disease surgery. This advanced system was developed with support from a CVS Group research program.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/cushings-syndrome-market?rk

Cushings Syndrome Market Segments

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Type: Exogenous Cushing's Syndrome, Endogenous Cushing's Syndrome

By Treatment: Medications Mifepristone, Pasireotide, Mitotane, Metyrapone, Surgery, Radiation Therapy, Chemotherapy, Others

By End Users: Hospitals, Specialty Clinics, Others

Regional Assessment:

Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Cushings Syndrome market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

In terms of geographical analysis, Cushings Syndrome Market report provides an in-depth view of:-

∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cushings-syndrome-market?rk

This report provides a 360-degree synopsis of the competitive scenario of the Cushings Syndrome industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports: https://www.datamintelligence.com/research-report/cushings-syndrome-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cushing's Syndrome Market is expected to reach US$ 291.1 million by 2031 growing with a CAGR of 8.96% | LGM Pharma, Sigma Aldrich, Tocris Bioscience. here

News-ID: 3969105 • Views:

More Releases from DataM Intelligence 4market Research LLP

Biomass Briquette Market to Grow at 7% CAGR from 2025 to 2031, Led by North America & Asia-Pacific with Key Players including Enviva Inc., Pinnacle Renewable Energy Inc., Drax Group plc, Arauco (Arauco Biomass), and RUF Briquetting Systems GmbH
Biomass Briquette Market to Grow at 7% CAGR from 2025 to 2031, Led by North Amer …
The Biomass Briquette Market is expected to expand at a CAGR of about 7% from 2025 to 2031 as industries and households increasingly adopt sustainable and eco‐friendly solid fuel alternatives to traditional fossil fuels, driven by rising energy demand and environmental concerns. Growth is supported by increasing demand across key applications such as industrial fuel, power generation, cooking fuel, and residential heating, driven by abundant agricultural and forestry residues that are
Protein Engineering Market to Grow at 15.6% CAGR from 2025 to 2033, Driven by North America (40% Share) with Key Players including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio‐Rad Laboratories Inc., Bruker Corporation, and GenScript Bio
Protein Engineering Market to Grow at 15.6% CAGR from 2025 to 2033, Driven by No …
The global protein engineering market reached US$ 2,854.54 Million in 2024 and is expected to reach US$ 8,646.10 Million by 2033, growing at a CAGR of 15.6 % from 2025 ro 2033 as demand for tailored biological solutions accelerates across pharmaceuticals, biotechnology, diagnostics, and industrial applications. Growth is supported by increasing adoption of advanced protein modification, design and synthesis techniques to develop high‐efficacy therapeutics, enzymes, and biomaterials, driven by rising
Substation Automation Market to Reach USD 67B by 2031 at 6.5% CAGR | Driven by Renewable Energy Integration
Substation Automation Market to Reach USD 67B by 2031 at 6.5% CAGR | Driven by R …
According to DataM Intelligence, the Substation Automation Market reached USD 41 billion in 2022 and is expected to reach USD 67 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2024-2031).The global Substation Automation Market is undergoing a significant transformation as utilities and grid operators modernize aging infrastructure and transition toward digital substations. Substation automation systems (SAS) integrate intelligent electronic devices (IEDs), communication networks, SCADA platforms,
Aluminum Market to Reach US$ 401.60 Billion by 2032 Driven by Infrastructure Growth, EV Adoption, and Rising Demand for Sustainable Materials
Aluminum Market to Reach US$ 401.60 Billion by 2032 Driven by Infrastructure Gro …
The Aluminum Market reached US$ 231.82 billion in 2024 and is expected to reach US$ 401.60 billion by 2032, growing at a CAGR of 7.11% during the forecast period 2025-2032. Growth is driven by rising demand across construction, automotive, aerospace, packaging, and electrical industries, where aluminum is valued for its lightweight properties, corrosion resistance, high strength-to-weight ratio, and recyclability. Increasing focus on vehicle lightweighting, electric vehicle production, and sustainable packaging solutions

All 5 Releases


More Releases for Cushing

Terence Cushing Launches Personal Pledge for Proactive Legal Readiness
Image: https://www.globalnewslines.com/uploads/2026/01/1768402291.jpg Terence Cushing, Phoenix, AZ, USA. Terence Cushing of Phoenix, Arizona outlines a personal commitment to prevention, clarity, and responsible decision-making in today's complex legal environment. Terence "Terry" Cushing, Senior Corporate Counsel and veteran litigation attorney, has announced the launch of a new personal pledge focused on proactive legal readiness, clear communication, and early risk awareness. The pledge reflects lessons drawn from nearly two decades in federal courts, private practice, and corporate
Cushing Syndrome Clinical Trial Pipeline Shows Potential with Active Contributio …
DelveInsight's "Cushing Syndrome Pipeline Insight 2026" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates
Cushing Syndrome Market Is Going to Boom | Major Giants HRA Pharma • Recordati …
Coherent Market Insights has released a report titled "Cushing Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. ➤ Christmas Exclusive Deal
Cushing Syndrome Market Trends is Electrifying Growth Cycle: Bristol Myers Squib …
The latest study released on the Global Cushing Syndrome Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Cushing Syndrome
Cushing Syndrome Market Is Booming So Rapidly | Recordati, Diurnal Group, Pfizer
The Global Cushing Syndrome Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 22.6% to reach $8.8 Billion by 2034. The latest study released on the Global Cushing Syndrome Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for